Literature DB >> 14107051

LEUKOKINETIC STUDIES. VII. MORPHOLOGY OF THE BONE MARROW AND BLOOD OF DOGS GIVEN VINBLASTINE SULFATE.

D R BOGGS, J W ATHENS, O P HAAB, P A CANCILLA, S O RAAB, G E CARTWRIGHT, M M WINTROBE.   

Abstract

Entities:  

Keywords:  BLOOD CELL COUNT; BONE MARROW; CELL DIVISION; DIETHYLCARBAMAZINE; DOGS; EOSINOPHILS; ERYTHROCYTES; EXPERIMENTAL LAB STUDY; LEUKOCYTES; LYMPHOCYTES; MONOCYTES; SULFATES; TOXICOLOGIC REPORT; VINBLASTINE

Mesh：

Substances：

Year:  1964        PMID： 14107051

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  LEUKOKINETIC STUDIES. IX. EXPERIMENTAL EVALUATION OF A MODEL OF GRANULOPOIESIS.

Authors:  D R BOGGS; J W ATHENS; G E CARTWRIGHT; M M WINTROBE
Journal:  J Clin Invest       Date:  1965-04       Impact factor: 14.808

Review 2.  [Kinetics and regulation of granulocytopoiesis (author's transl)].

Authors:  P Forrer
Journal:  Klin Wochenschr       Date:  1977-03-15

3.  Change in taste preference related to aging of taste cells in rat.

Authors:  K Sugimoto; T Sato
Journal:  Experientia       Date:  1978-05-15

4.  Regulation of erythropoiesis. 18. The effect of vincristine and erythropoietin on bone marrow.

Authors:  B S Morse; F Stohlman
Journal:  J Clin Invest       Date:  1966-08       Impact factor: 14.808

5.  Neutrophil kinetics in the dog.

Authors:  K A Deubelbeiss; J T Dancey; L A Harker; C A Finch
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

6.  Effects of vinblastine on catecholamine-biosynthetic enzymes in heart, sympathetic ganglion and adrenal glands of rats.

Authors:  I Hanbauer; I J Kopin; G D Maengwyn-Davies; N B Thoa; V K Weise
Journal:  Br J Pharmacol       Date:  1973-05       Impact factor: 8.739

7.  A mathematical model of canine granulocytopoiesis.

Authors:  K H Steinbach; H Raffler; G Pabst; T M Fliedner
Journal:  J Math Biol       Date:  1980-08       Impact factor: 2.259
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.